← Open Payments lookup

NANG IMMANIVONG: Open Payments

NPI 1538567102 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$553 in 18 payments from 10 companies in 2025. Trend: 2023 $17 · 2024 $176 · 2025 $553

Food & beverage: $553
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP6$201
ABIOMED2$145
Amgen Inc.2$38
Novo Nordisk Inc2$35
Bayer Healthcare Pharmaceuticals Inc.1$26
GlaxoSmithKline, LLC.1$25
Abbott Laboratories1$24
Exact Sciences Corporation1$23
Lilly USA, LLC1$20
ABBVIE INC.1$17

Products named: BREZTRI, REPATHA, Ozempic, AIRSUPRA, Kerendia, TRELEGY ELLIPTA, FREESTYLE LIBRE 3, The Cologuard Plus Collection Kit.

Industry payments across TX — which companies pay providers there.